GUWAHATI, June 22 - The 3rd foundation day function of the Cancer Research Foundation India (CRFI) was held earlier this week in the auditorium of the Dr B Borooah Cancer Institute (BBCI) here. The programme was held in association with the Department of Palliative Medicine of BBCI.
The foundation day oration was delivered by Dr MR Rajagopal, Chairman of Pallium India and Director of Trivandrum Institute of Palliative Care. He spoke on the topic ‘Advance directives, intensive care, and end-of-life care’.
During the function, the RK Borkotoky Best Research Paper 2018 was awarded to Dr Sheefa Mirza from the Department of Life Sciences, Gujarat University, Ahmedabad.
The award was received by Dr Rakesh Rawal on behalf of Dr Mirza.
Dr Mirza and her team had identified circulating cancer stem cells in blood of patients diagnosed with lung cancer. These cancer stem cells are responsible for the resistance to cancer-directed treatment in lung cancer patients, which was demonstrated by their gene expression profile.
Dr Mouchumee Bhattacharyya, vice chairperson and head of the scientific advisory committee of CRFI, said that the finding from the research would be useful to develop personalised treatment regimens like immunotherapy and targeted therapy for lung cancer patients.
Targeting and eliminating circulating cancer stem cells is essential to achieving cure in patients with lung cancer, Dr Bhattacharyya said.
CRFI is a not-for-profit organisation that was formed in 2015. The organisation has been able to make a significant impact among researchers in various fields of cancer research, stated Dr Amal Chandra Kataki, chairman of CRFI.
Dr Kataki said, “Only research will enhance our understanding of cancer and help us find and develop better strategies for its prevention, control, and finally lasting cure. CRFI will continue to support and promote cancer research that will help to fight this disease on all its fronts.”